Dysplasia-Associated Arterial Disease Precision Health Network (DAAD)

Overview

The MGI-DAAD (Dysplasia-Associated Arterial Disease) study is a research initiative aimed at enhancing the understanding and treatment of arterial diseases associated with dysplasia, such as fibromuscular dysplasia (FMD). The primary goal of the study is to identify and investigate genes involved in vascular remodeling (how blood vessels change shape and size) and their connection to cardiovascular disease. By uncovering the genetic mechanisms underlying rare vascular diseases, MGI-DAAD aims to gain insights into the cellular and molecular pathways relevant to both arterial dysplasia and more common vascular conditions, with the goal of developing personalized treatment strategies to improve patient outcomes.

Principal Investigator

Santhi Ganesh, MD

Digital Health Innovation Support

Digital Health Innovation provided funding for the processing of genetic data for this MGI Partner Study.